These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32974947)

  • 1. Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study.
    Schep SJ; van Dijk WEM; Beckers EAM; Meijer K; Coppens M; Eikenboom J; Leebeek FWG; van Vulpen LFD; Fischer KF; Schutgens REG;
    Am J Hematol; 2021 Jan; 96(1):51-59. PubMed ID: 32974947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up study.
    Pardos-Gea J; Altisent C; Parra R; Vilardell-Tarrès M; Ordi-Ros J
    Haemophilia; 2012 Sep; 18(5):789-93. PubMed ID: 22429259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
    Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A;
    Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Hemophilia A: A Retrospective Multicenter Analysis of 42 Patients.
    Liu Y; Ruan X; Lei P; Shang B; Zhu Z; Chen S; Wang D; Wang R; Li X; Xue F
    Clin Appl Thromb Hemost; 2023; 29():10760296221151165. PubMed ID: 36653966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 study.
    Holstein K; Liu X; Smith A; Knöbl P; Klamroth R; Geisen U; Eichler H; Miesbach W; Tiede A
    Blood; 2020 Jul; 136(3):279-287. PubMed ID: 32268359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.
    Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P
    Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.
    Lévesque H; Viallard JF; Houivet E; Bonnotte B; Voisin S; Le Cam-Duchez V; Maillot F; Lambert M; Liozon E; Hervier B; Fain O; Guillet B; Schmidt J; Luca LE; Ebbo M; Ferreira-Maldent N; Babuty A; Sailler L; Duffau P; Barbay V; Audia S; Benichou J; Graveleau J; Benhamou Y;
    Thromb Res; 2024 May; 237():79-87. PubMed ID: 38555718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China.
    Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R
    Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of 65 patients with acquired hemophilia A in Taiwan.
    Huang SY; Tsay W; Lin SY; Hsu SC; Hung MH; Shen MC
    J Formos Med Assoc; 2015 Apr; 114(4):321-7. PubMed ID: 25839765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study.
    Tiede A; Hofbauer CJ; Werwitzke S; Knöbl P; Gottstein S; Scharf RE; Heinz J; Groß J; Holstein K; Dobbelstein C; Scheiflinger F; Koch A; Reipert BM
    Blood; 2016 May; 127(19):2289-97. PubMed ID: 26912467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission.
    Ogawa Y; Yanagisawa K; Naito C; Uchiumi H; Ishizaki T; Shimizu H; Gohda F; Ieko M; Ichinose A; Handa H
    Int J Hematol; 2020 Apr; 111(4):544-549. PubMed ID: 31939075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired hemophilia a: retrospective analysis of 49 cases from a single Chinese hemophilia center.
    Yang Y; Xue F; Shi H; Wang H; Zhang L; Ji L; Yang R
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):35-40. PubMed ID: 23677912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China.
    Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W
    Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired hemophilia A: a single-center study of 165 patients.
    Yu D; Xue F; Liu X; Chen Y; Fu R; Sun T; Dai X; Ju M; Dong H; Yang R; Liu W; Zhang L
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102318. PubMed ID: 38433975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
    Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
    Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced-intensity, risk factor-stratified immunosuppression for acquired hemophilia A: single-center observational study.
    Dobbelstein C; Moschovakis GL; Tiede A
    Ann Hematol; 2020 Sep; 99(9):2105-2112. PubMed ID: 32621181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.